Acetarsol Suppositories: Effective Treatment for Refractory Proctitis in a Cohort of Patients with Inflammatory Bowel Disease

BACKGROUND: Management of proctitis refractory to conventional therapies presents a common clinical problem. The use of acetarsol suppositories, which are derived from organic arsenic, was first described in 1965. Data concerning clinical efficacy and tolerability are very limited. AIM: To examine t...

Descripción completa

Detalles Bibliográficos
Autores principales: Kiely, Christopher J., Clark, Angela, Bhattacharyya, Joya, Moran, Gordon W., Lee, James C., Parkes, Miles
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5854736/
https://www.ncbi.nlm.nih.gov/pubmed/29457211
http://dx.doi.org/10.1007/s10620-017-4890-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5854736/
https://www.ncbi.nlm.nih.gov/pubmed/29457211
http://dx.doi.org/10.1007/s10620-017-4890-6

Ejemplares similares